Back to search

Article

Low-dose Naltrexone (LDN) extends healthspan and lifespan through activation of the transcription factor SKN-1/NRF2 in C. elegans.

2023-06-14

Abstract excerpt

<title>Abstract</title> <p>Aging is a topic of urgency and importance, particularly as the world's aging population continues to grow. Numerous studies have been conducted to identify potential interventions that can improve health and promote longevity, however few are close to implementation. One promising approach to accelerate the implementation is drug repurposing, or using existing drugs for new indications...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
edaa9d54-d3b3-5c25-b4d4-ac43010be3e8
DOI
10.21203/rs.3.rs-2985642/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low-dose Naltrexone (LDN) extends healthspan and lifespan through activation of the transcription factor SKN-1/NRF2 in C. elegans.DOI 10.21203/rs.3.rs-2985642/v1
Select a neighboring publication to make it the new centre.